Valion Bio, Inc.

SEC 4 · Filed

0001683168-26-007396Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Sep 18, 2026

Exercise or conversion by Wolf Lisa G

Security
Restricted Stock Units
Code
M
Shares
4
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-09-18",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Each Restricted Stock Unit is convertible into one share of Common Stock.",
    "F3": "Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date.",
    "F4": "These numbers have been adjusted to reflect the reverse stock split of the Common Stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026."
  },
  "owners": [
    {
      "cik": "0001861556",
      "name": "Wolf Lisa G",
      "roles": [
        "officer"
      ],
      "title": "COO \u0026 CFO"
    }
  ],
  "ownership": "D",
  "post_shares": "19",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Restricted Stock Units",
  "shares": "4",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "4"
}
Insider transactionsEvent date Sep 18, 2026

Payment of exercise price or tax by delivery of securities by Wolf Lisa G

Security
Common Stock
Code
F
Shares
2
Price per share
2.12
Structured facts
{
  "code": "F",
  "date": "2026-09-18",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "The Reporting Person forfeited 2 shares of Common Stock upon vesting and settlement of 4 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer\u0027s Common Stock at the time of forfeiture.",
    "F4": "These numbers have been adjusted to reflect the reverse stock split of the Common Stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026."
  },
  "owners": [
    {
      "cik": "0001861556",
      "name": "Wolf Lisa G",
      "roles": [
        "officer"
      ],
      "title": "COO \u0026 CFO"
    }
  ],
  "ownership": "D",
  "post_shares": "27",
  "price": "2.12",
  "row": 2,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "2",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Sep 18, 2026

Exercise or conversion by Wolf Lisa G

Security
Common Stock
Code
M
Shares
4
Price per share
Unreported
Structured facts
{
  "code": "M",
  "date": "2026-09-18",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Each Restricted Stock Unit is convertible into one share of Common Stock.",
    "F3": "Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the \"Vesting Commencement Date\"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."
  },
  "owners": [
    {
      "cik": "0001861556",
      "name": "Wolf Lisa G",
      "roles": [
        "officer"
      ],
      "title": "COO \u0026 CFO"
    }
  ],
  "ownership": "D",
  "post_shares": "29",
  "price": null,
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "4",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}